Mechanism of Indications Contraindication Common Side Nursing

Action Effects Considerations

GENERIC NAME Glatiramer COPAXONE is Not  shortness  Monitor for

Glatiramer acetate
acetate indicated for Contraindicated of breath S&S of
modifies reduction of to the patient. compromised
BRAND NAME immune
immune the frequency  fever
Copaxone response
processes that of relapses in
CLASSIFICATION are responsible patients with  pain
 Assess for
Immunomodulator for the Relapsing-
pathogenesis of Remitting local
DOSE multiple Multiple reactions at
20 mg sclerosis (MS). Sclerosis injection sites
including
It is proposed
FREQUENCY erythema,
that the drug Rationale:
N/A itching,
serves as a patients who induration,
ROUTE
decoy to have and
S.Q locally- experienced a soreness.
generated first clinical
autoantibodies. episode and  Injection-site
These have MRI rotation and
antibodies, features skin
along with consistent with management
certain T-cells, multiple
are thereby sclerosis  Advise
neutralized patients that
before they can glatiramer
cause tissue acetate may
damage. cause various
symptoms
after injection,
including
flushing,
chest pain,
palpitations,
anxiety,
dyspnea,
constriction of
the throat,
and urticaria.
These
symptoms
are generally
transient and
self-limited
and do not
require
specific
treatment

https://www.pdr.net/drug-summary/Copaxone-glatiramer-acetate-568.8349
http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/G013.html